EARLY BUILD · 15 license-and-service checked provider listings · No patient data collected
← Compound library
Investigational / no FDA-approved-treatment claim

Humanin

A mitochondrial-derived peptide investigated in age-related disease models.

Regulatory status and key limits

Investigational / no FDA-approved-treatment claim

A mitochondrial-derived peptide investigated in age-related disease models.

Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.

Source checked October 10, 2026 · Editorial source review · Not medical advice
No dosing or purchase guidance. This information is not a recommendation to use a compound.

Purported uses, not established benefits

Proponents claim humanin may protect cells from stress and support metabolic or neurologic health during aging.

The cited review discusses experimental disease models and potential applications. It does not establish human longevity benefit or a safe treatment.

A claimed use is not proof of safety, effectiveness or FDA approval. Research-purpose-only labeling does not authorize human use.

Evidence and source limits

The source linked here describes research or investigational use. It does not establish an FDA-approved indication for this compound or for a research-chemical product. A claimed use is not an established benefit.

Product identity, purity, route, safety and suitability remain separate questions. Research-purpose-only labeling does not authorize human use. This note provides no dosing, preparation or purchase guidance.

Original source

Original source: Humanin ↗

Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.